Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Baxter
UBS
QuintilesIMS
Daiichi Sankyo
Boehringer Ingelheim
Farmers Insurance
Novartis
US Army
Cerilliant

Generated: August 17, 2017

DrugPatentWatch Database Preview

Acyclovir sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for acyclovir sodium and what is the scope of acyclovir sodium freedom to operate?

Acyclovir sodium
is the generic ingredient in four branded drugs marketed by Aurobindo Pharma Ltd, Glaxosmithkline, Zydus Pharms Usa Inc, Eurohlth Intl Sarl, Abbvie, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Teva Parenteral, Hikma Pharms Llc, Athenex Inc, and Apothecon, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are fifty-five drug master file entries for acyclovir sodium. Five suppliers are listed for this compound.

Summary for Generic Name: acyclovir sodium

Tradenames:4
Patents:0
Applicants:12
NDAs:18
Drug Master File Entries: see list55
Suppliers / Packagers: see list5
Bulk Api Vendors: see list148
Clinical Trials: see list2,461
Patent Applications: see list6,366
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:acyclovir sodium at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie
ACYCLOVIR
acyclovir sodium
INJECTABLE;INJECTION075114-001Jul 26, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
ACYCLOVIR SODIUM
acyclovir sodium
INJECTABLE;INJECTION074663-001Apr 22, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
ACYCLOVIR SODIUM
acyclovir sodium
INJECTABLE;INJECTION206606-001Jun 13, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
ACYCLOVIR SODIUM
acyclovir sodium
INJECTABLE;INJECTION074969-001Aug 26, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
ACYCLOVIR SODIUM
acyclovir sodium
INJECTABLE;INJECTION074897-002Feb 27, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: acyclovir sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline
ZOVIRAX
acyclovir sodium
INJECTABLE;INJECTION018603-001Oct 22, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
QuintilesIMS
Cantor Fitzgerald
US Army
Baxter
Cerilliant
Harvard Business School
Farmers Insurance
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot